METHYL SALICYLATE 10%

METHYL SALICYLATE 10% was reported 222 times

METHYL SALICYLATE 10% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I 1 0.1429
1 ANTICIPATORY ANXIETY 11 0.0404
2 CYCLIC NEUTROPENIA 1 0.0192
3 PERITONEAL INFECTION 1 0.0122
4 MEDICAL DEVICE ENTRAPMENT 1 0.0119
5 FOOD INTOLERANCE 39 0.0106
6 BACILLUS TEST POSITIVE 1 0.0101
7 ANAL POLYP 1 0.0097
8 ANAL EROSION 1 0.0091
9 RHEUMATIC HEART DISEASE 1 0.0088
10 ABDOMINAL WALL CYST 1 0.0082
11 MEDIASTINAL ABSCESS 1 0.0077
12 INJECTION SITE INFLAMMATION 38 0.0076
13 LEUKAEMIC INFILTRATION 1 0.0071
14 WOUND HAEMATOMA 1 0.0069
15 SERRATIA BACTERAEMIA 1 0.0068
16 DIAGNOSTIC PROCEDURE 1 0.0066
17 ULTRASOUND DOPPLER ABNORMAL 1 0.0058
18 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 1 0.0055
19 FAMILIAL MEDITERRANEAN FEVER 1 0.0051
20 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
21 SHUNT INFECTION 1 0.0044
22 UROSEPSIS 40 0.0043
23 VITAMIN B6 DEFICIENCY 1 0.0041
24 INTESTINAL SEPSIS 1 0.0038
25 GRANULOMA SKIN 3 0.0037
26 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
27 CARBUNCLE 1 0.0035
28 SCARLET FEVER 1 0.0031
29 NOROVIRUS TEST POSITIVE 1 0.0031
30 FUNGAL TEST POSITIVE 1 0.0028
31 ACETABULUM FRACTURE 1 0.0027
32 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
33 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
34 BLOOD PARATHYROID HORMONE DECREASED 3 0.0020
35 INFUSION SITE VESICLES 1 0.0019
36 WHITE COAT HYPERTENSION 1 0.0018
37 ENCEPHALOMALACIA 1 0.0018
38 BACTERIURIA 1 0.0018
39 STOMA SITE HYPERGRANULATION 1 0.0016
40 VAGINITIS BACTERIAL 1 0.0016
41 NEUTROPENIC SEPSIS 11 0.0015
42 INFUSION SITE URTICARIA 1 0.0015
43 PULMONARY FIBROSIS 28 0.0015
44 SUTURE RUPTURE 1 0.0014
45 SYNOVITIS 26 0.0014
46 DERMATITIS DIAPER 1 0.0014
47 HODGKIN'S DISEASE 1 0.0014
48 DRUG USE DISORDER 11 0.0013
49 MYOPERICARDITIS 1 0.0013
50 PANNICULITIS 3 0.0012
51 INCISION SITE COMPLICATION 1 0.0012
52 X-RAY ABNORMAL 2 0.0011
53 JOINT ARTHROPLASTY 2 0.0011
54 MUSCLE NECROSIS 1 0.0011
55 OVARIAN CYST 11 0.0011
56 RHEUMATOID NODULE 3 0.0011
57 DRUG TOLERANCE DECREASED 3 0.0011
58 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
59 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
60 IMPULSE-CONTROL DISORDER 2 0.0010
61 TEETH BRITTLE 1 0.0010
62 BURNS THIRD DEGREE 1 0.0009
63 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
64 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
65 PNEUMONIA STREPTOCOCCAL 1 0.0009
66 RETROPERITONEAL HAEMATOMA 2 0.0009
67 ANGIOEDEMA 39 0.0009
68 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
69 LIP ULCERATION 1 0.0009
70 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
71 ESCHERICHIA TEST POSITIVE 1 0.0008
72 BREATH SOUNDS ABNORMAL 4 0.0008
73 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
74 SKIN NECROSIS 4 0.0008
75 STOMA SITE INFECTION 1 0.0008
76 NON-HODGKIN'S LYMPHOMA 1 0.0008
77 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
78 HYPOAESTHESIA ORAL 11 0.0007
79 CORNEAL ABRASION 1 0.0007
80 INFUSION SITE RASH 1 0.0007
81 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
82 PULMONARY PAIN 2 0.0007
83 STOMA SITE PAIN 1 0.0007
84 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
85 NEOPLASM SKIN 1 0.0006
86 FUNGAEMIA 1 0.0006
87 ORTHOPNOEA 2 0.0006
88 ENTERITIS 4 0.0006
89 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
90 DEAFNESS BILATERAL 1 0.0006
91 HEPATIC ENZYME INCREASED 40 0.0006
92 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
93 SEPTIC SHOCK 25 0.0006
94 INFUSION SITE DISCHARGE 1 0.0006
95 ESSENTIAL HYPERTENSION 1 0.0005
96 LOBAR PNEUMONIA 1 0.0005
97 HEPATOTOXICITY 12 0.0005
98 STOMA SITE ERYTHEMA 1 0.0005
99 HYPERTENSIVE HEART DISEASE 1 0.0005
100 RHEUMATOID FACTOR POSITIVE 3 0.0005
101 JOINT INJURY 11 0.0005
102 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
103 MUSCLE HAEMORRHAGE 2 0.0005
104 GLOSSODYNIA 11 0.0005
105 DIVERTICULAR PERFORATION 1 0.0005
106 ARTHROPATHY 27 0.0005
107 DILATATION VENTRICULAR 1 0.0005
108 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
109 JAW FRACTURE 1 0.0005
110 RENAL TUBULAR ACIDOSIS 1 0.0005
111 CORNEAL DISORDER 1 0.0005
112 GASTRITIS 12 0.0005
113 BACTERIAL TEST POSITIVE 1 0.0004
114 BLOOD LOSS ANAEMIA 1 0.0004
115 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
116 METASTASES TO MENINGES 1 0.0004
117 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1 0.0004
118 NECK SURGERY 1 0.0004
119 DYSPEPSIA 42 0.0004
120 INFLAMMATION 22 0.0004
121 RETROPERITONEAL HAEMORRHAGE 1 0.0004
122 HYPERVOLAEMIA 2 0.0004
123 DRUG INTOLERANCE 39 0.0004
124 CATHETER SITE HAEMORRHAGE 1 0.0004
125 ENDODONTIC PROCEDURE 1 0.0004
126 VENTRICULAR DYSFUNCTION 1 0.0004
127 ACTINIC KERATOSIS 1 0.0004
128 MOOD SWINGS 12 0.0004
129 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
130 BLOOD SODIUM INCREASED 1 0.0004
131 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
132 RHEUMATOID ARTHRITIS 40 0.0004
133 HEART VALVE INCOMPETENCE 1 0.0003
134 PARAPLEGIA 1 0.0003
135 RALES 2 0.0003
136 INJECTION SITE PRURITUS 23 0.0003
137 GASTROINTESTINAL NECROSIS 1 0.0003
138 NIGHT SWEATS 11 0.0003
139 CREPITATIONS 1 0.0003
140 METABOLIC ENCEPHALOPATHY 1 0.0003
141 HYPERCAPNIA 1 0.0003
142 DYSCHEZIA 1 0.0003
143 INTRACARDIAC THROMBUS 1 0.0003
144 BLOOD CREATININE DECREASED 1 0.0003
145 INFUSION SITE PRURITUS 1 0.0003
146 IRIDOCYCLITIS 1 0.0003
147 POLYMYALGIA RHEUMATICA 1 0.0003
148 EXPOSURE TO TOXIC AGENT 1 0.0003
149 LIVER ABSCESS 1 0.0003
150 MUSCULOSKELETAL STIFFNESS 27 0.0003
151 POSTURE ABNORMAL 1 0.0003
152 TREATMENT FAILURE 25 0.0003
153 PEPTIC ULCER 1 0.0003
154 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
155 LARGE INTESTINE PERFORATION 2 0.0003
156 ECZEMA 15 0.0003
157 APPARENT DEATH 1 0.0003
158 DRY EYE 13 0.0003
159 HYPOALBUMINAEMIA 2 0.0003
160 WOUND SECRETION 1 0.0003
161 SKIN PAPILLOMA 1 0.0002
162 BLEPHARITIS 1 0.0002
163 LIVER DISORDER 11 0.0002
164 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
165 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
166 SMALL INTESTINAL OBSTRUCTION 3 0.0002
167 HYPERCALCAEMIA 3 0.0002
168 AORTIC DISSECTION 1 0.0002
169 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
170 COAGULOPATHY 4 0.0002
171 CHAPPED LIPS 1 0.0002
172 ILEUS PARALYTIC 1 0.0002
173 ABDOMINAL HERNIA 1 0.0002
174 LUMBAR VERTEBRAL FRACTURE 1 0.0002
175 ISCHAEMIA 1 0.0002
176 HYPERTENSION 46 0.0002
177 EPISTAXIS 16 0.0002
178 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
179 SUBCUTANEOUS ABSCESS 1 0.0002
180 LETHARGY 12 0.0002
181 HUMERUS FRACTURE 1 0.0002
182 HYPERCHOLESTEROLAEMIA 2 0.0002
183 ABDOMINAL TENDERNESS 1 0.0002
184 HYPERNATRAEMIA 1 0.0002
185 CORONARY ARTERY STENOSIS 1 0.0002
186 KLEBSIELLA INFECTION 1 0.0002
187 DYSPHORIA 1 0.0002
188 PATHOLOGICAL FRACTURE 1 0.0002
189 ASTHMA 22 0.0002
190 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
191 SKIN ULCER 5 0.0002
192 BASAL CELL CARCINOMA 3 0.0002
193 POLYARTHRITIS 1 0.0002
194 ULCER 3 0.0002
195 ANAL ABSCESS 1 0.0002
196 SLEEP DISORDER 13 0.0002
197 HYDROCEPHALUS 1 0.0002
198 JAW DISORDER 1 0.0002
199 DEAFNESS UNILATERAL 1 0.0002
200 ARTHRITIS 14 0.0002
201 URINARY TRACT INFECTION 30 0.0002
202 CARDIAC VALVE DISEASE 1 0.0002
203 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
204 EXERCISE TOLERANCE DECREASED 1 0.0002
205 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
206 DRUG ERUPTION 3 0.0002
207 CARDIAC PACEMAKER INSERTION 1 0.0002
208 GOUT 3 0.0002
209 CHOLANGITIS 1 0.0002
210 SWELLING OF EYELID 1 0.0002
211 INFUSION SITE SWELLING 1 0.0002
212 GASTRIC ULCER 3 0.0002
213 ERECTILE DYSFUNCTION 4 0.0002
214 WALKING AID USER 1 0.0002
215 PRURITUS 58 0.0002
216 TERMINAL STATE 1 0.0001
217 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
218 BRONCHIECTASIS 1 0.0001
219 DYSGEUSIA 11 0.0001
220 UVEITIS 2 0.0001
221 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
222 PNEUMONIA 47 0.0001
223 HALLUCINATION, VISUAL 3 0.0001
224 PULMONARY TOXICITY 1 0.0001
225 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
226 GASTROENTERITIS 2 0.0001
227 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
228 ARTHROPOD BITE 1 0.0001
229 RENAL FAILURE CHRONIC 1 0.0001
230 HAEMOLYSIS 1 0.0001
231 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
232 FEMUR FRACTURE 4 0.0001
233 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
234 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
235 FURUNCLE 1 0.0001
236 DISORIENTATION 5 0.0001
237 RENAL CYST 1 0.0001
238 TRICUSPID VALVE INCOMPETENCE 1 0.0001
239 INTENTIONAL PRODUCT MISUSE 11 0.0001
240 ATRIAL FLUTTER 1 0.0001
241 STENT PLACEMENT 1 0.0001
242 DYSKINESIA 5 0.0001
243 DECUBITUS ULCER 1 0.0001
244 OSTEOPOROSIS 5 0.0001
245 BLOOD UREA INCREASED 2 0.0001
246 HAEMODIALYSIS 1 0.0001
247 CARDIAC MURMUR 1 0.0001
248 MUCOSAL INFLAMMATION 3 0.0001
249 SPINAL OSTEOARTHRITIS 1 0.0001
250 TUMOUR LYSIS SYNDROME 1 0.0001
251 PRODUCT COMMUNICATION ISSUE 1 0.0001
252 LUNG INFILTRATION 1 0.0001
253 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
254 EXOSTOSIS 1 0.0001
255 NERVE COMPRESSION 1 0.0001
256 SPINAL DISORDER 1 0.0001
257 SLEEP APNOEA SYNDROME 2 0.0001
258 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
259 AFFECT LABILITY 1 0.0001
260 ATELECTASIS 1 0.0001
261 SINUS BRADYCARDIA 1 0.0001
262 BACK PAIN 24 0.0001
263 COELIAC DISEASE 1 0.0001
264 UPPER LIMB FRACTURE 2 0.0001
265 PRESCRIBED UNDERDOSE 2 0.0001
266 EMPHYSEMA 1 0.0001
267 VAGINAL DISCHARGE 1 0.0001
268 EYELID PTOSIS 1 0.0001
269 DRY THROAT 1 0.0001
270 NEUTROPHIL COUNT INCREASED 1 0.0001
271 RIB FRACTURE 2 0.0001
272 PERITONITIS 2 0.0001
273 HYPERBILIRUBINAEMIA 1 0.0001
274 TENDERNESS 1 0.0001
275 DERMATITIS 2 0.0001
276 KNEE ARTHROPLASTY 2 0.0001
277 BREAST CANCER METASTATIC 1 0.0001
278 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
279 CONDITION AGGRAVATED 28 0.0001
280 MENTAL DISORDER 4 0.0001
281 PULMONARY THROMBOSIS 1 0.0001
282 CONSTIPATION 20 0.0001
283 TOOTH FRACTURE 1 0.0001
284 DENTAL CARIES 1 0.0001
285 NERVE INJURY 1 0.0001
286 DRY SKIN 12 0.0001
287 MALNUTRITION 1 0.0001
288 SKIN INFECTION 1 0.0001
289 ELECTROLYTE IMBALANCE 1 0.0001
290 VASCULITIS 1 0.0001
291 COVID-19 PNEUMONIA 1 0.0001
292 BACTERAEMIA 1 0.0001
293 PRODUCTIVE COUGH 4 0.0001
294 HYPERLIPIDAEMIA 1 0.0001
295 MOBILITY DECREASED 6 0.0001
296 C-REACTIVE PROTEIN INCREASED 3 0.0001
297 ADRENAL INSUFFICIENCY 1 0.0001
298 NOCTURIA 1 0.0001
299 SCHIZOPHRENIA 1 0.0001
300 CYTOPENIA 1 0.0001
301 CARDIOMEGALY 1 0.0001
302 TENDON RUPTURE 1 0.0001
303 CYST 1 0.0001
304 ILEUS 1 0.0001
305 TOOTH EXTRACTION 1 0.0001
306 CELLULITIS 4 0.0001
307 HEPATITIS 2 0.0001
308 ROTATOR CUFF SYNDROME 1 0.0001
309 GENITAL HAEMORRHAGE 1 0.0001
310 INFUSION SITE PAIN 1 0.0001
311 ABDOMINAL PAIN 18 0.0001
312 ARTHRALGIA 32 0.0001
313 DEAFNESS 2 0.0001
314 SEDATION 2 0.0001
315 BEDRIDDEN 1 0.0001
316 PULMONARY CONGESTION 1 0.0001
317 SARS-COV-2 TEST POSITIVE 1 0.0001
318 EAR INFECTION 2 0.0001
319 ABORTION SPONTANEOUS 3 0.0001
320 HAIR TEXTURE ABNORMAL 1 0.0001
321 MALIGNANT MELANOMA 1 0.0001
322 JOINT RANGE OF MOTION DECREASED 1 0.0001
323 SINUS CONGESTION 1 0.0001
324 RASH PRURITIC 4 0.0001
325 DECREASED APPETITE 17 0.0001
326 CORONARY ARTERY OCCLUSION 1 0.0001
327 ORAL DISCOMFORT 1 0.0001
328 COORDINATION ABNORMAL 1 0.0001
329 APHONIA 1 0.0001
330 MASS 1 0.0001
331 BLOOD TEST ABNORMAL 1 0.0001
332 SEASONAL ALLERGY 1 0.0001
333 DIALYSIS 1 0.0001
334 SINUS TACHYCARDIA 1 0.0001
335 RED BLOOD CELL COUNT DECREASED 2 0.0001
336 ANGINA PECTORIS 2 0.0001
337 DRUG DEPENDENCE 11 0.0001
338 ASCITES 2 0.0001
339 CARDIOMYOPATHY 1 0.0001
340 PULMONARY MASS 1 0.0001
341 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
342 RASH 29 0.0001
343 CORONARY ARTERY DISEASE 2 0.0001
344 ECONOMIC PROBLEM 1 0.0001
345 PLEURAL EFFUSION 4 0.0001
346 HIP ARTHROPLASTY 1 0.0001
347 DEVICE RELATED INFECTION 1 0.0001
348 LYMPHOMA 1 0.0001
349 ANKLE FRACTURE 1 0.0001
350 CYANOSIS 1 0.0001
351 ABDOMINAL PAIN UPPER 13 0.0001
352 OBESITY 1 0.0001
353 SENSORY DISTURBANCE 1 0.0001
354 INTERSTITIAL LUNG DISEASE 3 0.0001
355 DEPRESSION 14 0.0001
356 BACK DISORDER 1 0.0001
357 BLOOD CREATININE INCREASED 4 0.0001
358 ALOPECIA 12 0.0001
359 PHOTOSENSITIVITY REACTION 1 0.0001
360 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
361 EXPIRED PRODUCT ADMINISTERED 2 0.0001
362 FALL 20 0.0001
363 LIP SWELLING 2 0.0001
364 SKIN DISORDER 2 0.0001
365 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
366 CANDIDA INFECTION 1 0.0001
367 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
368 ORTHOSTATIC HYPOTENSION 1 0.0001
369 BURNING SENSATION 4 0.0001
370 HYPOXIA 2 0.0001
371 DIARRHOEA 36 0.0001
372 LEUKOCYTOSIS 1 0.0001
373 TOOTHACHE 1 0.0001
374 END STAGE RENAL DISEASE 1 0.0001
375 DYSURIA 2 0.0001
376 CONJUNCTIVITIS 1 0.0001
377 INFLUENZA 6 0.0001
378 THINKING ABNORMAL 1 0.0001
379 BACTERIAL INFECTION 1 0.0001
380 MIDDLE INSOMNIA 1 0.0001
381 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
382 HEPATIC CIRRHOSIS 1 0.0001
383 BLOOD SODIUM DECREASED 1 0.0001
384 PROTEINURIA 1 0.0001
385 MUSCULOSKELETAL DISORDER 1 0.0001
386 POST PROCEDURAL COMPLICATION 1 0.0001
387 CHOKING 1 0.0001
388 PREGNANCY 1 0.0000
389 CYTOKINE RELEASE SYNDROME 1 0.0000
390 CARDIAC FAILURE CONGESTIVE 4 0.0000
391 PROSTATE CANCER 4 0.0000
392 PRODUCT ADMINISTRATION ERROR 1 0.0000
393 THERAPEUTIC RESPONSE DECREASED 3 0.0000
394 BONE MARROW FAILURE 1 0.0000
395 PRODUCT PREPARATION ERROR 1 0.0000
396 MOUTH ULCERATION 1 0.0000
397 OFF LABEL USE 41 0.0000
398 NAUSEA 37 0.0000
399 DEEP VEIN THROMBOSIS 3 0.0000
400 VAGINAL HAEMORRHAGE 2 0.0000
401 ANXIETY 13 0.0000
402 PERIPHERAL SWELLING 7 0.0000
403 INFUSION RELATED REACTION 3 0.0000
404 RENAL FAILURE 6 0.0000
405 TRANSAMINASES INCREASED 1 0.0000
406 HEART RATE IRREGULAR 1 0.0000
407 PAIN 27 0.0000
408 ERYTHEMA 9 0.0000
409 SHOCK 1 0.0000
410 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
411 BLOOD CHOLESTEROL INCREASED 2 0.0000
412 ASTHENIA 16 0.0000
413 ARRHYTHMIA 2 0.0000
414 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
415 COMA 2 0.0000
416 DIABETIC KETOACIDOSIS 1 0.0000
417 LOCALISED INFECTION 1 0.0000
418 RESPIRATORY FAILURE 3 0.0000
419 CEREBRAL INFARCTION 1 0.0000
420 LUNG DISORDER 2 0.0000
421 LIVER INJURY 1 0.0000
422 ENCEPHALOPATHY 1 0.0000
423 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
424 PNEUMONIA ASPIRATION 1 0.0000
425 HEADACHE 25 0.0000
426 ACUTE KIDNEY INJURY 6 0.0000
427 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
428 UNRESPONSIVE TO STIMULI 1 0.0000
429 ABDOMINAL DISTENSION 4 0.0000
430 DEHYDRATION 5 0.0000
431 DRY MOUTH 3 0.0000
432 LIMB INJURY 1 0.0000
433 PNEUMONITIS 1 0.0000
434 INFLUENZA LIKE ILLNESS 3 0.0000
435 DRUG INEFFECTIVE 48 0.0000
436 HAEMATOCHEZIA 2 0.0000
437 ABNORMAL DREAMS 1 0.0000
438 DIVERTICULITIS 1 0.0000
439 MENTAL STATUS CHANGES 1 0.0000
440 MEDICATION ERROR 2 0.0000
441 OXYGEN SATURATION DECREASED 2 0.0000
442 HYPONATRAEMIA 2 0.0000
443 INTENTIONAL DOSE OMISSION 1 0.0000
444 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
445 HERPES ZOSTER 2 0.0000
446 SEIZURE 4 0.0000
447 INFECTION 5 0.0000
448 DYSSTASIA 1 0.0000
449 MALAISE 15 0.0000
450 ACUTE MYOCARDIAL INFARCTION 1 0.0000
451 WHEEZING 2 0.0000
452 RESPIRATORY DISORDER 1 0.0000
453 ADVERSE DRUG REACTION 3 0.0000
454 IRRITABILITY 2 0.0000
455 LACRIMATION INCREASED 1 0.0000
456 ADVERSE EVENT 3 0.0000
457 LIMB DISCOMFORT 1 0.0000
458 WEIGHT DECREASED 9 0.0000
459 DRUG-INDUCED LIVER INJURY 1 0.0000
460 DYSPHAGIA 3 0.0000
461 DRUG INTERACTION 5 0.0000
462 HYPOTHYROIDISM 1 0.0000
463 FATIGUE 24 0.0000
464 AMNESIA 2 0.0000
465 SWELLING FACE 2 0.0000
466 PAIN IN EXTREMITY 9 0.0000
467 OSTEONECROSIS 1 0.0000
468 HEART RATE INCREASED 3 0.0000
469 FEBRILE NEUTROPENIA 2 0.0000
470 VISUAL ACUITY REDUCED 1 0.0000
471 INSOMNIA 8 0.0000
472 URINARY RETENTION 1 0.0000
473 GAIT INABILITY 1 0.0000
474 SOMNOLENCE 6 0.0000
475 TOXICITY TO VARIOUS AGENTS 5 0.0000
476 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
477 ANGER 1 0.0000
478 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
479 HAEMOGLOBIN DECREASED 3 0.0000
480 ILLNESS 3 0.0000
481 NIGHTMARE 1 0.0000
482 DELIRIUM 1 0.0000
483 HYPERKALAEMIA 1 0.0000
484 LYMPHADENOPATHY 1 0.0000
485 HYPERGLYCAEMIA 1 0.0000
486 EYE SWELLING 1 0.0000
487 HALLUCINATION 2 0.0000
488 MUSCULAR WEAKNESS 3 0.0000
489 CHRONIC KIDNEY DISEASE 2 0.0000
490 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
491 PLASMA CELL MYELOMA 1 0.0000
492 PALPITATIONS 3 0.0000
493 ABNORMAL BEHAVIOUR 1 0.0000
494 JOINT SWELLING 3 0.0000
495 DEVICE BREAKAGE 1 0.0000
496 OEDEMA PERIPHERAL 3 0.0000
497 BLINDNESS 1 0.0000
498 CARDIAC ARREST 2 0.0000
499 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
500 RHABDOMYOLYSIS 1 0.0000
501 POLLAKIURIA 1 0.0000
502 RENAL IMPAIRMENT 2 0.0000
503 RENAL FAILURE ACUTE 1 0.0000
504 HYPOACUSIS 1 0.0000
505 BALANCE DISORDER 2 0.0000
506 MYOCARDIAL INFARCTION 4 0.0000
507 DRUG WITHDRAWAL SYNDROME 2 0.0000
508 TACHYCARDIA 2 0.0000
509 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
510 MEMORY IMPAIRMENT 3 0.0000
511 HYPERSENSITIVITY 4 0.0000
512 RENAL DISORDER 1 0.0000
513 BREAST CANCER 2 0.0000
514 VOMITING 10 0.0000
515 PULMONARY EMBOLISM 2 0.0000
516 ANAEMIA 4 0.0000
517 MIGRAINE 2 0.0000
518 MULTIPLE SCLEROSIS 1 0.0000
519 CONTUSION 2 0.0000
520 HYPOGLYCAEMIA 1 0.0000
521 ATRIAL FIBRILLATION 2 0.0000
522 PRODUCT DOSE OMISSION ISSUE 6 0.0000
523 FLUID RETENTION 1 0.0000
524 BLOOD PRESSURE INCREASED 3 0.0000
525 CHEST DISCOMFORT 2 0.0000
526 HOSPITALISATION 3 0.0000
527 DYSPNOEA 11 0.0000
528 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
529 MUSCULOSKELETAL PAIN 1 0.0000
530 SPEECH DISORDER 1 0.0000
531 PARAESTHESIA 3 0.0000
532 DEPRESSED MOOD 1 0.0000
533 BRADYCARDIA 1 0.0000
534 SEPSIS 2 0.0000
535 ABDOMINAL DISCOMFORT 3 0.0000
536 COUGH 5 0.0000
537 BLISTER 1 0.0000
538 EYE PAIN 1 0.0000
539 MYALGIA 3 0.0000
540 SURGERY 1 0.0000
541 FEELING ABNORMAL 4 0.0000
542 STOMATITIS 1 0.0000
543 ILL-DEFINED DISORDER 1 0.0000
544 VERTIGO 1 0.0000
545 MUSCLE SPASMS 3 0.0000
546 FEELING HOT 1 0.0000
547 PRODUCT USE ISSUE 3 0.0000
548 BLOOD GLUCOSE INCREASED 3 0.0000
549 GAIT DISTURBANCE 3 0.0000
550 LOSS OF CONSCIOUSNESS 2 0.0000
551 BLOOD PRESSURE DECREASED 1 0.0000
552 NEOPLASM MALIGNANT 1 0.0000
553 HYPOTENSION 3 0.0000
554 NEUTROPENIA 2 0.0000
555 INJURY 1 0.0000
556 AGITATION 1 0.0000
557 BRONCHITIS 1 0.0000
558 HOT FLUSH 1 0.0000
559 THROMBOSIS 1 0.0000
560 CONFUSIONAL STATE 2 0.0000
561 DIZZINESS 6 0.0000
562 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
563 URTICARIA 2 0.0000
564 CEREBROVASCULAR ACCIDENT 2 0.0000
565 PYREXIA 4 0.0000
566 PRODUCT STORAGE ERROR 1 0.0000
567 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
568 COVID-19 2 0.0000
569 GASTROINTESTINAL DISORDER 1 0.0000
570 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
571 SUICIDAL IDEATION 1 0.0000
572 CHEST PAIN 2 0.0000
573 CARDIAC DISORDER 1 0.0000
574 SWELLING 1 0.0000
575 NEUROPATHY PERIPHERAL 1 0.0000
576 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
577 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
578 SINUSITIS 1 0.0000
579 PLATELET COUNT DECREASED 1 0.0000
580 OVERDOSE 2 0.0000
581 THROMBOCYTOPENIA 1 0.0000
582 DISEASE PROGRESSION 1 0.0000
583 VISUAL IMPAIRMENT 1 0.0000
584 INJECTION SITE ERYTHEMA 1 0.0000
585 HYPERHIDROSIS 1 0.0000
586 PRODUCT QUALITY ISSUE 1 0.0000
587 VISION BLURRED 1 0.0000
588 DEATH 6 0.0000
589 TREMOR 1 0.0000
590 NO ADVERSE EVENT 1 0.0000
591 NASOPHARYNGITIS 1 0.0000
592 WEIGHT INCREASED 1 0.0000